Michael P. Carroll

Hereditary Hemochromatosis

Corwin Q. Edwards, Michael P. Carroll, Paul Bray et al. · New England Journal of Medicine · 1977 · 141 citations

Iron Metabolism, Pathology, Iron Deficiency +18

Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study

Paul G. Richardson, Asher Chanan‐Khan, Sagar Lonial et al. · British Journal of Haematology · 2011 · 110 citations

Safety and Observations from a Placebo-Controlled, Crossover Study to Assess Use of Autologous Umbilical Cord Blood Stem Cells to Improve Symptoms in Children with Autism

Michael Chez, Christopher Lepage, Carol Parise et al. · Stem Cells Translational Medicine · 2018 · 64 citations · Full text

Assess Use, Crossover Trial, Socialization Subscales +16

Enantioselective construction of sterically hindered tertiary α-aryl ketones: a catalytic asymmetric synthesis of isoflavanones

Michael P. Carroll, Helge Müller‐Bunz, Patrick J. Guiry · Chemical Communications · 2012 · 39 citations

Tertiary α-Aryl Ketones, Catalytic Asymmetric Synthesis, Engineering +12

A Multicenter Phase 1 Clinical Trial of Tanespimycin (KOS-953) + Bortezomib (BZ): Encouraging Activity and Manageable Toxicity in Heavily Pre-Treated Patients with Relapsed Refractory Multiple Myeloma (MM).

Paul G. Richardson, Asher Chanan‐Khan, Sagar Lonial et al. · Blood · 2006 · 38 citations